Cancer Letters
Volume 210, Issue 1 , Pages 81-84 , 8 July 2004

Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells

Received 9 January 2004 ,Accepted 13 January 2004.

References 

  1. Seno H, Oshima M, Ishikawa T, Oshima H, Takaku K, Chiba T, et al. Cyclooxygenase-2 and prostaglandin E2 receptor EP2-dependent angiogenesis in ApcΔ716 mouse intestinal polyps. Cancer Res. 2002;62:506–511
  2. Sonoshita M, Takaku K, Sasaki N, Sugimoto Y, Ushikubi F, Narumiya S, et al. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice. Nat. Med. 2001;7:1048–1051
  3. Watanabe K, Kawamori T, Nakatsugi S, Ohta T, Ohuchida S, Yamamoto H, et al. Role of prostaglandin E receptor subtype EP1 in colon carcinogenesis. Cancer Res. 1999;59:5093–5096
  4. Mutoh M, Watanabe K, Kitamura T, Shoji Y, Takahashi M, Kawamori T, et al. Involvement of prostaglandin E receptor subtype EP4 in colon carcinogenesis. Cancer Res. 2002;62:28–32
  5. Sheng H, Shao J, Washington KM, DuBois RN. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 2001;276:18075–18081
  6. Yang VW, Shields JM, Hamilton SR, Spannhake EW, Hubbard WC, Hylind LM, et al. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. Cancer Res. 1998;58:1750–1753
  7. Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo X-J, Ramonetti JT, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomataous polyposis. Cancer Res. 1996;56:2556–2560
  8. Yoshida T, Ohki S, Kanazawa M, Mizunuma H, Kikuchi Y, Satoh H, et al. Inhibitory effects of prostaglandin D2 against the proliferation of human colon cancer cell lines and hepatic metastasis from colorectal cancer. Jpn. J. Surg. 1998;28:740–745
  9. Monneret G, Cossette C, Gravel S, Rokach J, Powell WS. 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor antagonist in human eosinophils. J. Pharm. Exp. Therap. 2003;304:349–355
  10. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 2001;193:255–261
  11. Hirai H, Tanaka K, Takano S, Ichimasa M, Nakamura M, Nagata K. Agonistic effect of indomethacin on a prostaglandin D2 receptor CRTH2. J. Immunol. 2002;168:981–985
  12. Hull MA, Gardner SH, Hawcroft G. The activity of the non-steroidal anti-inflammatory drug indomethacin against colorectal cancer. Cancer Treat. Rev. 2003;29:309–320
  13. Hawcroft G, Gardner SH, Hull MA. Activation of peroxisome proliferator-activated receptor γ does not explain the anti-proliferative activity of the non-steroidal anti-inflammatory drug indomethacin on human colorectal cancer cells. J. Pharmacol. Exp. Therap. 2003;305:632–637
  14. Smith M-L, Hawcroft G, Hull MA. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur. J. Cancer. 2000;36:664–674
  15. Willson JKV, Bittner GN, Oberley TD, Meisner LF, Weese JL. Cell culture of human colon adenomas and carcinomas. Cancer Res. 1987;47:2704–2713
  16. Wright DH, Nantel F, Metters KM, Ford-Hutchinson AW. A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor. Eur. J. Pharmacol. 1999;377:101–115
  17. Urade Y, Hayashi O. Prostaglandin D2 and sleep regulation. Biochim. Biophys. Acta. 1999;1436:606–615
  18. Wright DH, Ford-Hutchinson AW, Chadee K, Metters KM. The human prostanoid DP receptor stimulates mucin secretion in LS174T cells. Br. J. Pharmacol. 2000;131:1537–1545
  19. Lesuffleur T, Kornowski A, Luccioni C, Muleris M, Barbat A, Beaumatin J, et al. Adaptation to 5-fluorouracil of the heterogeneous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation. Int. J. Cancer. 1991;49:721–730
  20. Sawyer N, Cauchon E, Chateauneuf A, Cruz RPG, Nicholson DW, Metters KM, et al. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br. J. Pharmacol. 2002;137:1163–1172
  21. Forman BM, Tontonoz P, Chen J. 15-deoxy-D12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARg. Cell. 1995;83:803–812
  22. Brockman JA, Gupta RA, DuBois RN. Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology. 1998;115:1049–1055

PII: S0304-3835(04)00060-6

doi: 10.1016/j.canlet.2004.01.015

Cancer Letters
Volume 210, Issue 1 , Pages 81-84 , 8 July 2004

Article Tools

* Image Usage & Resolution